🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s ELV Holdings & Trades

First Buy
Q3 2015
Duration Held
34 Quarters
Largest Add
Q3 2018
+1.01 M Shares
Current Position
3,465 Shares
$1.35 M Value

Lee Ainslie's ELV Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 3,465 shares of Elevance Health, Inc. (ELV) worth $1.35 M, representing 0.01% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 34 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 1.01 M shares. Largest reduction occurred in Q2 2019, reducing 724,153 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's Elevance Health (ELV) Holding Value Over Time

Track share changes against reported price movement

Quarterly Elevance Health (ELV) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +3,465 New Buy 3,465 $388.82
Q1 2024 -2,057 Sold Out 0 $0.00
Q4 2023 +2,057 New Buy 2,057 $471.56
Q3 2023 -1,889 Sold Out 0 $0.00
Q2 2023 +1,889 New Buy 1,889 $444.29
Q1 2023 -508 Sold Out 0 $0.00
Q4 2022 -36 Reduce 6.62% 508 $512.97
Q3 2022 +544 New Buy 544 $454.04
Q2 2022 -3,729 Sold Out 0 $0.00
Q1 2022 +3,217 Add 628.32% 3,729 $491.28
Q4 2021 -89 Reduce 14.81% 512 $462.89
Q3 2021 -5,468 Reduce 90.10% 601 $372.71
Q2 2021 +5,878 Add 3077.49% 6,069 $381.78
Q1 2021 +71 Add 59.17% 191 $361.26
Q4 2020 -10,934 Reduce 98.91% 120 $325.00
Q3 2020 +2,691 Add 32.18% 11,054 $268.59
Q2 2020 -7,030 Reduce 45.67% 8,363 $262.94
Q1 2020 +15,393 New Buy 15,393 $227.05
Q2 2019 -724,153 Sold Out 0 $0.00
Q1 2019 -169,596 Reduce 18.98% 724,153 $286.98
Q4 2018 -150,413 Reduce 14.41% 893,749 $262.63
Q3 2018 +1.01 M Add 3059.34% 1.04 M $274.05
Q2 2018 -6,380 Reduce 16.18% 33,050 $238.03
Q1 2018 +10,230 Add 35.03% 39,430 $219.71
Q4 2017 +10,560 Add 56.65% 29,200 $225.00
Q3 2017 +5,810 Add 45.28% 18,640 $189.86
Q2 2017 +4,540 Add 54.76% 12,830 $188.15
Q1 2017 -240 Reduce 2.81% 8,290 $165.38
Q4 2016 -950 Reduce 10.02% 8,530 $143.73
Q3 2016 +180 Add 1.94% 9,480 $125.32
Q2 2016 +870 Add 10.32% 9,300 $131.29
Q1 2016 +2,690 Add 46.86% 8,430 $139.03
Q4 2015 +890 Add 18.35% 5,740 $139.37
Q3 2015 +4,850 New Buy 4,850 $140.00

Lee Ainslie's Elevance Health Investment FAQs

Lee Ainslie first purchased Elevance Health, Inc. (ELV) in Q3 2015, acquiring 4,850 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held Elevance Health, Inc. (ELV) for 34 quarters since Q3 2015.

Lee Ainslie's largest addition to Elevance Health, Inc. (ELV) was in Q3 2018, adding 1,044,162 shares worth $286.15 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 3,465 shares of Elevance Health, Inc. (ELV), valued at approximately $1.35 M.

As of the Q3 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in Elevance Health, Inc. (ELV) was 1,044,162 shares, as reported at the end of Q3 2018.